IPP Bureau
Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries
By IPP Bureau - May 25, 2022
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
Max Healthcare Institute Q4 FY2022 consolidated PAT slips QoQ to Rs. 123.73 Cr
By IPP Bureau - May 25, 2022
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
By IPP Bureau - May 25, 2022
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
By IPP Bureau - May 25, 2022
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
By IPP Bureau - May 24, 2022
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
By IPP Bureau - May 24, 2022
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections
By IPP Bureau - May 24, 2022
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
By IPP Bureau - May 24, 2022
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Apollo Hospitals Navi Mumbai doctors perform critical procedure to save 14-month-old baby girl
By IPP Bureau - May 24, 2022
Successfully removed peanut from the child’s left lung through bronchoscopy
HNZ Lifesciences unveils its new brand Amio Wellness
By IPP Bureau - May 24, 2022
The key categories include intimate wellness, skincare & hair care
AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases
By IPP Bureau - May 24, 2022
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Lonza to expand inhalation capabilities at Tampa site
By IPP Bureau - May 24, 2022
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
NHA announces revamped ABHA mobile application
By IPP Bureau - May 24, 2022
The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)
Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device
By IPP Bureau - May 23, 2022
Objective tracking data combined with cohort data to drive medicine of the future
Vaxzevria approved in the EU as third dose booster against Covid-19
By IPP Bureau - May 23, 2022
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
